Triomics raises $15M Series A to automate cancer clinical trials matching

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly reduce the time it takes doctors to match […]

© 2024 TechCrunch. All rights reserved. For personal use only.

automate biotech & health cancer clinical clinical trials generative generative ai healthcare generative ai startup investigations medicines patients raises reduce save series series a startup startups triomics united united states venture